search icon
  • Apple, Inc AAPL
  • S&P 500 ETF Trust SPDR SPY
  • Alphabet Inc. - Class A Shares GOOGL
  • Microsoft Corporation MSFT
  • Meta Platforms Inc META
  • Netflix, Inc. NFLX
  • Amazon.com Inc. AMZN
  • Spotify Technology SA SPOT
    kynb-img

    Kyntra Bio Inc Share Price

    KYNB
    NSQ
    $9.546
    +$0.05
    (0.53%)
    1D
    Sector: Healthcare

    Analyst Forecast

    Overview Returns Financials Ratios News FAQs

    Price Chart

    Key Metrics

    Market Cap info-icon
    This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
     $0
    P/E Ratio info-icon
    This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
     0
    Volume info-icon
    This is the total number of shares traded during the most recent trading day.
     1.58K
    Avg Volume info-icon
    This is the average number of shares traded during the most recent 30 days.
     0
    Dividend Yield info-icon
    This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
     0.00%
    Beta info-icon
    This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
     0
    52-week Range info-icon
    This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
    $4.85 L
    $21.95 H
    $9.546

    About Kyntra Bio Inc, Common Stock

    FibroGen, Inc. is a biopharmaceutical company focused on the development of novel therapies at the frontiers of cancer biology and anemia. It is developing FG-3246, a potential first-in-class antibody-drug conjugate (ADC) targeting CD46, for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and potentially other cancers. This program also includes the development of FG-3180, an associated CD46-targeted positron emission tomography (PET) biomarker and imaging agent. It is also developing Roxadustat, an oral medication, first-in-class, oral small molecule hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), which is evaluated for the treatment of anemia in patients with chronic kidney disease (CKD), anemia associated with myelodysplastic syndromes and chemotherapy-induced anemia. Roxadustat is approved in China, Europe, Japan, and numerous other countries for the treatment of anemia of CKD in adult patients on dialysis (DD) and not on dialysis (NDD). more

    Sector: Healthcare

    Returns

    Data is not properly formatted.

    Ratios

    Asset Efficiency

    These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

    KYNB
    ROA (LTM) 0.00%
    ROE (LTM) 0.00%

    Valuation

    These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

    KYNB
    Trailing PE NM
    Forward PE NM
    P/S (TTM) 0.00
    P/B 0.00
    EV/R 0.00
    EV/Ebitda NM

    Discover more

    Tsla
    Tesla, Inc.
    aaple
    Apple, Inc.
    GOOGL
    Alphabet Inc. - Class A Shares
    META
    Meta Platforms Inc
    AMZN
    Amazon.com Inc.
    Microsoft
    Microsoft Corporation
    NVDA
    NVIDIA Corporation
    BRK
    Berkshire Hathaway Inc. Hld B
    LLY
    Eli Lilly and Company

    FAQs

    What is Kyntra Bio Inc share price today?

    Kyntra Bio Inc (KYNB) share price today is $9.546

    Can Indians buy Kyntra Bio Inc shares?

    Yes, Indians can buy shares of Kyntra Bio Inc (KYNB) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KYNB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

    Can Fractional shares of Kyntra Bio Inc be purchased?

    Yes, you can purchase fractional shares of Kyntra Bio Inc (KYNB) via the Vested app. You can start investing in Kyntra Bio Inc (KYNB) with a minimum investment of $1.

    How to invest in Kyntra Bio Inc shares from India?

    You can invest in shares of Kyntra Bio Inc (KYNB) via Vested in three simple steps:

    • Click on Sign Up or Invest in KYNB stock at the top of this page
    • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
    • Transfer USD funds to your US Brokerage account and start investing in Kyntra Bio Inc shares

    What is Kyntra Bio Inc 52-week high and low stock price?

    The 52-week high price of Kyntra Bio Inc (KYNB) is $21.95. The 52-week low price of Kyntra Bio Inc (KYNB) is $4.85.

    What is Kyntra Bio Inc price-to-earnings (P/E) ratio?

    The price-to-earnings (P/E) ratio of Kyntra Bio Inc (KYNB) is

    What is Kyntra Bio Inc price-to-book (P/B) ratio?

    The price-to-book (P/B) ratio of Kyntra Bio Inc (KYNB) is 0.00

    What is Kyntra Bio Inc dividend yield?

    The dividend yield of Kyntra Bio Inc (KYNB) is 0.00%

    What is the Market Cap of Kyntra Bio Inc?

    The market capitalization of Kyntra Bio Inc (KYNB) is

    What is Kyntra Bio Inc's stock symbol?

    The stock symbol (or ticker) of Kyntra Bio Inc is KYNB

    Feedback

    Signup to access all features and start your US investing journey!

    • Open your account in minutes
    • Take your portfolio global, starting at just $1
    Get started

    Add ticker to compare

    Scroll to Top